A novel treatment for refractory dermatomyositis: A systematic review of anifrolumab and dermatomyositis
- PMID: 40228662
- DOI: 10.1016/j.jaad.2025.04.025
A novel treatment for refractory dermatomyositis: A systematic review of anifrolumab and dermatomyositis
Keywords: anifrolumab; dermatomyositis.
Conflict of interest statement
Conflicts of interest None disclosed.
LinkOut - more resources
Full Text Sources